 should
be treated with an antiplatelet agent and a cholesterollowering agent, preferentially a statin, unless there are
speciï¬c contraindications.
The preoperative evaluation and workup should be
expedited in patients with CMI to avoid any untoward
events and progression to AMI. There is a spectrum of
symptoms for patients with CMI that range from intermittent, mild postprandial pain to persistent pain, unrelated to any oral